1-9 of 9
C Carter
Close
Sort by
Journal Articles

Impact of PARP Inhibitor and Platinum Therapy on Clonal Hematopoiesis

Jeremy T. Baeten, Irenaeus C.C. Chan, Lea Moukarzel, Amber C. Carter, Minal Patel, Konrad H. Stopsack, Paul Pharoah, James Brenton, Bob T Li, Wassim Abida, Alison M. Schram, Karen Cadoo, Britta Weigelt, Carlos Cruchaga, Howard Scher, Ross L Levine, Elli Papaemmanuil, Daniel C. Link, Kelly L. Bolton
Journal: Blood
Blood (2023) 142 (Supplement 1): 1315.
https://doi.org/10.1182/blood-2023-190457
Published: 2023
Journal Articles

Enhanced Cell-Associated Fibrinolytic Pathway but Not Coagulation Pathway Activity Contributes to Motility in Metastatic Breast Cancer Cells.

Jennifer C Carter, PhD, Robert A Campbell, PhD, Jennifer A Gibbons, PhD, Alisa S. Wolberg, PhD, Frank C. Church, PhD
Journal: Blood
Blood (2009) 114 (22): 3170.
https://doi.org/10.1182/blood.V114.22.3170.3170
Published: 2009
Journal Articles

Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses

R. Childs, E. Clave, N. Contentin, D. Jayasekera, N. Hensel, S. Leitman, E.J. Read, C. Carter, E. Bahceci, N.S. Young, A.J. Barrett
Journal: Blood
Blood (1999) 94 (9): 3234–3241.
https://doi.org/10.1182/blood.V94.9.3234
Published: 1999
Journal Articles

Reed-Sternberg Cell Genome Expression Supports a B-Cell Lineage

Jeffrey Cossman, Christina M. Annunziata, Steven Barash, Louis Staudt, Patrick Dillon, Wei-Wu He, Paola Ricciardi-Castagnoli, Craig A. Rosen, Kenneth C. Carter
Journal: Blood
Blood (1999) 94 (2): 411–416.
https://doi.org/10.1182/blood.V94.2.411
Published: 1999
Journal Articles

Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33

Ann L. Cornish, Sylvie Freeman, Gareth Forbes, Jian Ni, Mei Zhang, Mario Cepeda, Reiner Gentz, Meena Augustus, Kenneth C. Carter, Paul R. Crocker
Journal: Blood
Blood (1998) 92 (6): 2123–2132.
https://doi.org/10.1182/blood.V92.6.2123
Published: 1998
Journal Articles

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

D Mavroudis, E Read, M Cottler-Fox, D Couriel, J Molldrem, C Carter, M Yu, C Dunbar, J Barrett
Journal: Blood
Blood (1996) 88 (8): 3223–3229.
https://doi.org/10.1182/blood.V88.8.3223.bloodjournal8883223
Published: 1996
Journal Articles

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

CE Dunbar, M Cottler-Fox, JA O'Shaughnessy, S Doren, C Carter, R Berenson, S Brown, RC Moen, J Greenblatt, FM Stewart
Journal: Blood
Blood (1995) 85 (11): 3048–3057.
https://doi.org/10.1182/blood.V85.11.3048.bloodjournal85113048
Published: 1995
Journal Articles

A diagnostic test for heparin-induced thrombocytopenia

D Sheridan, C Carter, JG Kelton
Journal: Blood
Blood (1986) 67 (1): 27–30.
https://doi.org/10.1182/blood.V67.1.27.27
Published: 1986
Journal Articles

Subpopulation heterogeneity in human acute myeloid leukemia determined by monoclonal antibodies

S Pessano, A Palumbo, D Ferrero, GL Pagliardi, L Bottero, SK Lai, P Meo, C Carter, H Hubbell, B Lange
Journal: Blood
Blood (1984) 64 (1): 275–281.
https://doi.org/10.1182/blood.V64.1.275.275
Published: 1984